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The Stability study: a protocol for a
multicenter randomized clinical trial
comparing anterior cruciate ligament
reconstruction with and without Lateral
Extra-articular Tenodesis in individuals who
are at high risk of graft failure
Alan Getgood1, Dianne Bryant2, Andrew Firth3* and Stability Group
Abstract
Background: The purpose of anterior cruciate ligament reconstruction (ACLR) is to restore stability to the knee.
Persistent rotational laxity following ACLR has been correlated with poor outcome and graft failure. We hypothesize
that anterolateral complex reconstruction by way of a Modified Lemaire Lateral Extra-articular Tenodesis (LET) in
combination with single bundle ACLR would reduce the risk of persistent rotatory laxity in young individuals who
are deemed as being at high risk of failure. We will conduct a pragmatic, multicenter, randomized clinical trial
comparing standard single bundle hamstring ACLR with combined ACLR and LET.
Methods: Six-hundred patients (300 per group) aged 25 years or less with an ACL deficient knee that meet two of
the following three criteria will be included: 1) Grade 2 pivot shift or greater; 2) Returning to high risk cutting or
pivoting sports; 3) Generalized ligamentous laxity. Participants will be seen at 3-months, 6-months, 12-months and
24-months post-operatively. The primary outcome measure is graft failure requiring revision ACLR or symptomatic
instability associated with a positive asymmetric pivot shift indicating persistent rotational laxity. Patients will
complete secondary outcome measures at each follow-up visit including patient-reported outcome measures,
functional and biomechanical testing, and magnetic resonance imaging.
Discussion: This protocol is the first adequately powered randomized clinical trial investigating the effects of
augmenting ACLR with an LET in patients at high-risk of graft failure. The successful completion of this trial has the
potential to change surgical practice and provide evidence for the role of the LET in ACLR.
Trial registration: The trial is registered at ClinicalTrials.gov: NCT02018354, 23-12-2013.
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Background
The aim of anterior cruciate ligament reconstruction
(ACLR) is to regain functional stability of the knee fol-
lowing anterior cruciate ligament (ACL) injury, allowing
patients to return to their pre-injury level of activity.
The reconstruction procedure has evolved significantly
since the first ACLR was performed in the early 1900s
[1] and while the techniques have changed, the goal of
the surgery remains the same. A number of published
meta-analyses have compared stability rates and func-
tional outcomes of patellar tendon graft versus ham-
string tendon graft and autograft versus allograft for
ACL reconstruction [2–6]. The results have demon-
strated that ACL reconstruction fails to restore normal
knee stability [3, 5] regardless of graft choice, as rota-
tional laxity [2, 4, 6] and anterior translation [2, 6] per-
sist following surgery. Mohtadi et al. [7] conducted a
level 1 randomized controlled trial comparing patella
tendon (PT) grafts to single bundle hamstring (HT) and
double bundle hamstring (DB) grafts. A significant num-
ber of patients in all three groups had rotational laxity
characterized by a pivot shift greater or equal to 2 (HT
– 19%; PT – 16%; DB – 21%). Abnormal tibial rotation
has also been demonstrated in biomechanical assess-
ment of traditional ACL reconstructions compared to
the contralateral knee in functional tasks such as de-
scending stairs [8], pivoting [8], and running [9]. Geor-
goulis et al. [10] later confirmed that a traditionally
placed hamstring graft would not restore the normal
knee joint kinematics. A positive pivot shift and ongoing
rotational laxity has been shown to correlate with clinical
outcome [11], which may be associated with graft failure
and subsequent revision surgery. Studies investigating the
epidemiology and risk factors for graft failure following an
ACLR have found that younger patients (< 20 years old)
[12–16], patients with physiologic knee hyperextension
[17], and patients returning to pivoting sports [16] are at
greater risk of re-injury.
Recently, a significant focus has been placed upon the
anterolateral complex (ALC) of the knee, which includes
the iliotibial band, anterolateral ligament (ALL) and lateral
meniscus [18, 19]. Injuring these structures may contrib-
ute to rotational laxity about the knee [20, 21]. Cadaveric
studies have demonstrated that when the both the ACL
and ALL are sectioned, ACLR alone is insufficient to con-
trol knee rotation [22, 23]. Augmentation of ACLR with
an extra-articular reconstruction has been recommended
[22], and subsequently, the addition of a lateral extra-ar-
ticular tenodesis (LET) was found to outperform an ALL
reconstruction for controlling pivot shift [23].
Extra-articular reconstruction is not a new concept;
early approaches to ACL deficiency included LET and
several techniques were published [24]. Reports of poor
results [25, 26] eventually resulted in this approach
giving way to more advanced intra-articular procedures;
however, a number of authors performed the extra-ar-
ticular tenodesis along with intra-articular reconstruc-
tion and reported excellent results [27–30]. In 2015,
Hewison et al. [31] conducted a meta-analysis of trials
(n = 29; 8 randomized, 21 non-randomized) comparing
ACLR alone to ACLR combined with an LET and found
that the combined ACL and LET procedure signifi-
cantly reduced rotational laxity assessed by pivot shift
(odds ratio, 0.50 [95% confidence interval: 0.32 to
0.78], p = 0.002). There were no differences between
groups for International Knee Documentation Scores
(IKDC) or anterior laxity assessed by KT-1000/− 2000,
though the majority of included studies demonstrated
a high or unclear risk of bias and lacked sufficient
sample size indicating a need for further research.
The goal of providing a rotationally stable knee follow-
ing ACLR remains difficult to achieve. It is hypothesized
that poor rotational control, and hence a positive pivot
shift, may predispose patients to future graft failure and
need for revision surgery. This is particularly problem-
atic in young patients returning to pivoting sport, who
have been shown to be at a much higher risk of early
graft failure. A surgical procedure that addresses rota-
tional control is therefore of utmost importance when
treating the ACL deficient knee. The Stability Study is a
pragmatic, multicenter, randomized clinical trial (RCT)
where patients will be randomized to ACLR with or
without an LET in a 1:1 ratio. The purpose of this study
is to determine whether ACL reconstruction augmented
with a modified Lemaire LET results in a reduced rate
of graft failure compared to ACL reconstruction alone in
patients who are at high risk of graft failure. To our
knowledge, this will be the first level 1 study adequately
powered to detect a clinically relevant reduction in graft
failure, following a combination of intra-articular ACL
reconstruction with lateral extra-articular tenodesis in
patients who are deemed as being at higher risk of early
graft failure. This study will answer important questions
on how best to control rotational stability of the knee,
and whether this has an effect on resultant graft failure
in high risk individuals.
Methods
Study setting
Patients will be recruited from orthopedic sport medi-
cine clinics at 7 sites in Canada (Fowler Kennedy Sport
Medicine Clinic, London ON; McMaster University,
Hamilton ON; Banff Sport Medicine Clinic, Banff AB;
Pan Am Sport Medicine Clinic, Winnipeg MB; Fraser
Health Authority, New Westminster BC; Queen’s
University, Kingston ON; University of Calgary Sport
Medicine Centre, Calgary AB) and 2 sites in Europe
(Antwerp Orthopedic Center, Antwerp BE; University
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Hospitals Coventry and Warwickshire NHS Trust, Cov-
entry UK). Patients will be referred to orthopedic sur-
geons at these centres, where the clinician will screen
for potential participants and provide information about
the research study. See Fig. 1 for an outline of the study.
Eligibility criteria
Patients will be eligible to participate if they have an
ACL deficient knee and are skeletally mature (as defined
by closed growth plates on plain radiograph) between 15
and 25 years of age. Patients must also have two or more
of the following criteria: competitive pivoting sport,
grade two (2) pivot shift or greater, generalized ligament
laxity (Beighton score of four (4) or greater). Patients
will not be eligible to participate if they have had pre-
vious ACLR on either knee, a multi-ligament injury
(two or more ligaments requiring surgical attention),
symptomatic articular cartilage defect requiring treat-
ment other than debridement, varus or valgus mala-
lignment greater than three (3) degrees, unable to
speak or read English and unable to provide informed
consent (Table 1).
Intervention
All patients will undergo an anatomic ACLR. All ACLRs
will be performed in a standardized fashion across sites.
Specifically, surgeons will use a four-strand autologous
hamstring autograft. If the diameter of the graft is found
to be less than 8 mm, semitendinosus will be tripled (5
strand graft) providing a greater graft diameter. Femoral
tunnels will be drilled using an anteromedial portal tech-
nique, with femoral fixation provided by an Endobutton
or equivalent. Tibial fixation will be provided by interfer-
ence screw.
Patients randomized to receive LET
All LETs will be performed in a standardized fashion
across sites. Specifically, surgeons will make an oblique
skin incision between the lateral epicondyle and Gerdy’s
tubercle, measuring approximately 5 cm. A 1 cm wide ×
8 cm long strip of iliotibial band is fashioned, leaving the
Gerdy’s tubercle attachment intact. A No. 1 vicryl whip
suture is applied to the free end, leaving the needle
attached. The graft is then tunneled under the fibular
collateral ligament (FCL) and attached to the femur with
Fig. 1 Study Flow Diagram
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a Richards’ staple (Smith & Nephew), just distal to the
intermuscular septum, proximal to the femoral insertion
of the fibular collateral ligament. Fixation is performed
with the knee at 70° flexion, neutral rotation. Minimal ten-
sion is applied to the graft. The free end is then looped
back onto itself and sutured using the No. 1 vicryl.
All patients, regardless of group allocation will
undergo identical postoperative rehabilitation. Focus is
placed upon early range of motion and weight bearing as
tolerated. No brace is used. Briefly, this includes:
 0–6 weeks: General range of motion, swelling
control, quadriceps activation, muscle stretching and
strengthening.
 6–12 weeks: Range of motion, muscle strength,
proprioception, cardiovascular fitness.
 3–6 months: Flexibility and sport specific muscle
strengthening. Cardiovascular fitness.
 6–9 months: Sport specific training.




The primary outcome is a composite endpoint of graft
failure, defined as either: symptomatic instability requir-
ing revision ACL surgery, or symptomatic instability
with positive pivot shift or asymmetrical pivot shift
greater than the contralateral side. The purpose of
extra-articular reconstruction is to provide greater
rotational control, and therefore potentially reduce the
incidence of traumatic or atraumatic graft failure. There-
fore, it follows that if a positive pivot shift is present,
then the extra-articular reconstruction has failed.
Secondary outcomes
Secondary outcome measures will include patient-re-
ported quality of life and functional outcome
measures, functional testing and biomechanical as-
sessment, return to activity, imaging, cost effectiveness
and adverse events.
Patient-reported quality of life
We will measure disease-specific quality of life using the
ACL Quality of Life Questionnaire (ACL-QOL). The
ACL-QOL has five domains that query physical symp-
toms, occupational concerns, recreational activities,
lifestyle, and social and emotional aspects. Each item has
one 100 mm visual analogue scale response option, with
labeled anchors at 0 mm (e.g., extremely difficult) and
100 mm (e.g., not difficult at all). Scores are calculated
by converting the average of each of the five domain
scores to a total average score out of 100% where
100% represents the best possible score. The
ACL-QOl has demonstrated validity [32] in patients
with ACL injury and responsiveness to change [33] in
patients following ACLR.
We will measure region-specific quality of life using
the Knee Osteoarthritis and outcomes Score (KOOS).
The KOOS is a 42-item knee-specific questionnaire with
five separately reported domains, including pain (9
items), other symptoms (7 items), function in daily living
(17 items), function in sports/recreation (5 items) and
knee-related quality of life (4 items). Domain scores rep-
resent the average of all items in the domain standard-
ized to a score from 0 to 100 (worst to best). This
instrument has demonstrated reliability, validity and
responsiveness in patients undergoing ACLR [34].
We will measure quality-adjusted life years (QALYs)
using the European Quality of Life Scale (Euro-QoL)
[35]. The EuroQoL comprises two sections, the EQ-5D
index and the EQ-5D visual analogue scale (VAS). The
EQ-5D index is a 5-item standardized generic measure
of HRQOL that includes domains of mobility, self-care,
usual activities, pain and discomfort and anxiety and
depression. Each item is score using a 3-point response
scale and each combination of response choices
describes a health state (243 unique health states). Each
health state can be converted to a utility value from 0
(worst) to 1.0 (best) using a scoring formula. The EQ-5D
VAS is a 0 (worst) to 100 (best) scale that assesses
patient-perceived health status. The EQ-5D index and
VAS have demonstrated good test-retest reliability (0.73
and 0.70 respectively) and good cross-sectional construct
Table 1 Eligibility Criteria
Inclusion Criteria Exclusion Criteria
1. Skeletally mature between the ages of 15 and 25 1. Previous ACLR on either knee
2. ACL deficient knee 2. Multi-ligament injury (2+ ligaments requiring surgical attention)
3. Two or more of the following: 3. Symptomatic articular cartilage defect requiring treatment other
than debridement
a) Competitive pivoting sport 4. Varus or valgus malalignment greater than 3 degrees
b) Pivot shift grade 2 or greater 5. Unable to speak or read English
c) Generalized ligamentous laxity (Beighton
score of 4 or greater)
6. Unable to provide informed consent
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validity in patients with rheumatoid arthritis [36] and those
with osteoarthritis of the knee and is able to discriminate
between functional classes in patients with arthritis.
Patient-reported functional outcomes
The International Knee Documentation Committee Sub-
jective Knee Form (IKDC) is a knee-specific functional
outcome that consists of 18-items asking patients about
symptoms (7 items), sports activities (10 items) and
function (1 item). Likert scales, a dichotomized item and
11-point rating scales make up the response options,
and total score ranges from 0 (total limitation) and 100
(no limitations). The IKDC has shown adequate
test-retest reliability and good construct validity in
patients with issues at the knee [37].
The Lower Extremity Functional Score (LEFS) is a
self-report functional outcome containing 20 items with
five response options each. Responses range from 0
(extreme difficulty) to 4 (no difficulty) and the total
score is found by summing the responses for a max-
imum score of 80, which indicates high functional level.
The LEFS has demonstrated excellent test-retest reliabil-
ity (0.94) and construct validity in patients with lower
extremity issues [38].
The 4-Item Pain Intensity Measure (P4) is a four-item
questionnaire that asks patients to report the amount of
pain they experience throughout the day (morning,
afternoon, evening) and with activity. Each item
response is a visual analog scale ranging from 0 (no
pain) to 10 (pain as bad as it can be). The total score is
calculated by summing the four responses to a max-
imum score of 40. The P4 has demonstrated good
test-retest reliability (0.78) and the ability to detect
changes in pain intensity in patients with acute muscle
and joint injuries [39].
Objective functional outcomes
We will assess range of motion (ROM) by measuring
passive knee extension and active-assisted knee flexion.
For passive knee extension, the patient is seated with
both legs extended on a table, heel propped so that the
calf and upper thigh clear the treatment table. We will
instruct the patient to relax both quadriceps and
hamstrings to assure passive measurement. For
active-assisted knee flexion, the patient is seated with
both legs extended on a table. We will instruct them to
perform active-assisted knee flexion by placing one hand
under their thigh to initiate flexion and then clasp both
hands just below the tibial tuberosity. We will measure
and record flexion and extension in degrees using a
goniometer. For both measurements, we will centre the
fulcrum of the goniometer over the lateral epicondyle of
the femur. We will then align the stationary arm of the
goniometer with the greater trochanter of the femur and
the moving arm with the lateral malleolus at the ankle.
Strength testing will be performed using a computer-
ized isokinetic dynamometer. Each test consists of six
consecutive alternating knee flexion (three repetitions)
and extension (three repetitions) movements and is
assessed by using maximal concentric muscle actions at
an angular velocity of 90°/s. During each test session, we
will have the patient seated with his/her back against a
backrest oriented at 80° above the horizontal and his/her
hips in approximately 80° of flexion. We will secure the
patient’s pelvis using a seatbelt oriented diagonally
across the anterior superior iliac spines to the dyna-
mometer seat and backrest. We will position the axis of
rotation of the dynamometer lever arm coaxial to the
lateral femoral epicondyle. Once we have the patient
positioned correctly, we will familiarize them with the
testing apparatus and ask them to perform at least four
practice contractions before testing. During each test,
we will provide the patient with a 30-s rest period
between movements.
The hop test is a performance-based outcome measure
designed to evaluate neuromuscular control, strength
and confidence in the limb. The test is a combination of
four different hop tests that incorporate a variety of
movement principles (e.g., direction of change, speed,
acceleration-deceleration) that mimic the demands of
knee stability during sporting activities. We will ask
patients to perform the single hop for distance test by
standing on the leg to be tested, then hopping and land-
ing on the same limb. The kinesiologist will measure
and record the distance hopped at the level of the great
toe. We will have patients complete the timed 6-m hop
test by performing large one-legged hops in series over
the total distance. The kinesiologist will start the stop-
watch when the patient’s heel lifts from the starting pos-
ition and will stop it at the moment the testing foot
passes the finish line. We will have the patient complete
the triple hops for distance test by standing on one leg,
then performing three consecutive hops on the same leg
landing as far as possible. We will measure and record
the total distance covered by the three consecutive hops.
We will ask patients to perform the crossover hop for
distance by having the patient stand on the leg to be
tested, then hop forward three times while alternately
crossing over the width of the line (15-cm wide). We will
measure and record the total distance covered by the
crossover hops. We will offer a rest period between types
of hop tests (up to two minutes) and between individual
hop test trials if needed. Based on the performance of all
four tests, we will calculate the limb symmetry index
(test performance of the operative limb expressed as a
percentage of the opposite limb), to differentiate and
compare knee stability and rehabilitation strategies. This
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instrument has demonstrated validity and excellent
test-retest reliability [40].
Biomechanical assessment
Drop vertical jump (DVJ) assessment will take place in
the in the Wolf Orthopaedic Biomechanics Laboratory
(WOBL) using motion analysis equipment. We will use
autoreflective markers to track movements. We will
instruct patientsto step off an elevated platform (box
with a height of 31 cm) and land on a force plate with
both feet. Upon contact with the force plate, we will
have patients perform a vertical jump and re-land in the
spot of initial contact. We will then use data collected by
the force plates and reflective markers to calculate a
peak knee abduction moment (simply defined as the
distance between the joint axis and the vector produced
by the ground reaction force). Peak knee abduction mo-
ment has been shown to predict the risk of ACL injury
in young female athletes [41], and will therefore be used
as a surrogate outcome for reinjury within our study.
During this task, we will have a clinician and re-
searcher assess the biomechanics of the Drop Vertical
Jump using a Clinician Rated Drop Vertical Jump Scale.
This scale is being incorporated to test its validity and
reliability. We will video record the patient’s torso and
lower body while they perform this task. We will have
the clinician and researcher review the video footage for
comparison to their original scores.
Imaging
We will assess the articular cartilage in the lateral
compartment of the knee, using quantitative magnetic
resonance imaging (qMRI). Specifically, T1rho and T2
relaxation times are sensitive to changes in collagen and
proteoglycan content of articular cartilage [42, 43], typic-
ally observed following ACL injury [44, 45]. Increases in
T1rho or T2 relaxation time have been shown to be pre-
dictive of the development of OA [46]. Participants will
undergo MRI at 24 months postoperative. Participants
with a meniscal root tear will undergo MRI at 12 months
and 24 months postoperative to assess healing. Scans will
be performed on a 3 T Siemens Magnetom Trio magnet,
and a 15-channel Siemens PRISMA knee coil (Siemens
Medical Solutions, New Jersey, USA). qMRI pulse
sequences consist of a Sagittal Multi-Echo Spin Echo T2
Mapping sequence, and a 16-shot Gradient Echo T1rho
Mapping sequence.
We will also evaluate radiographical evidence of OA
using plain anteroposterior, Rosenberg and lateral view
radiographs. Joint space degeneration will be evaluated
by a clinician using the Kellgren-Lawrence Grading
Scale [47], which ranges from 0 (normal joint space) to
grade 4 (large osteophytes, marked narrowing of joint
space, severe sclerosis and deformity of bone contour).
Return to activity
The MARX Activity Rating Scale (MARS) is a four-item
activity rating scale. The patient is asked to rate how
often they were able to perform each activity (e.g. run-
ning, cutting, decelerating, and pivoting) in their most
healthy and active state. The patient is provided with five
categories of frequency of each functional activity, ran-
ging from less than one time in a month to four or more
times in a week. One point is allocated for each category
of frequency and a maximum score of 16 points can be
awarded. The MARS has demonstrated excellent test-re-
test reliability and construct validity in patients with dis-
orders of the knee [48].
We will look at return to sport by asking patients to
report their primary sport and level of participation
prior to injury. Following surgery, we will ask patients
to record the date they returned to their primary sport
and level and provide reasons they chose not to return
if so indicated.
Adverse events and cost outcomes
We will record adverse events including wound compli-
cations, infections, painful hardware, re-operation (e.g.
meniscal injuries, etc), and radiographic evidence of
osteoarthritis (radiographs are part of routine care).
A research assistant at each site will contact patients
who have experienced an adverse event to capture cost
data associated with the event. The cost form consists of
12 domains (emergency room visits and hospitalizations,
family doctor visits, specialist visits and outpatient
clinics, health care professional visits, tests, procedures
and surgeries, prescription medications, supplies and
equipment, over-the-counter medications, employment
statues and time-off work from paid employment, assist-
ance from others, assistance living and transportation
and miscellaneous costs) that patients self-report.
Participant timeline
After the patient has been screened and signed the in-
formed consent document, we will schedule a pre-operative
baseline appointment. At baseline, we will have patients
undergo a clinical assessment, range of motion, complete
the seven patient-reported questionnaires along with demo-
graphics and a pre-op return to sport questionnaire, and
perform the strength testing. Post-operatively, we will see
participants at 3months, 6months, 12months and 24
months for further follow-up (Table 2).
Recruitment
Patients presenting to the participating centres will first
be diagnosed by an orthopaedic surgeon. After diagnosis,
the surgeon will introduce and briefly outline the
research study to the patient. The surgeon will then ask
the patient if a member of the research team (graduate
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student or research assistant) can contact them with fur-
ther information about the study. Upon receiving patient
approval, a member of the research team will contact
the patient with more information. The patient will be
given the necessary time to consider participation in the
study and will accept or decline once they have come to
a decision.
Patients under the age of 18 will be provided with in-
formation about the study and will be asked to provide
their consent along with legal guardian consent. Parents
or guardians that are present at the appointment will be
included in the informed consent process. If parents or
guardians are not present the patient will be given the
opportunity to discuss their participation with their




Potential participants will be screened by an independent
clinician. Upon determining willingness to participate,
confirming eligibility and meniscal status intra-operatively,
a research assistant will enter the patient’s date of birth,
sex and meniscus status before randomizing the patient
via telephone or web-based randomization system to
ACLR alone or ACLR with LET.
Allocation (sequence generation)
All patients will be randomized by surgeon using a
standard randomization design whereby each surgeon
performs either ACLR alone or ACLR with LET in a 1:1
ratio. Randomization is stratified by surgeon, sex and
meniscal tear status (presence or absence of meniscal re-
pair requiring a change in postoperative rehabilitation)
in permuted block sizes of two and four to ensure that
the difference in outcome attributable to surgeon is
equally dispersed between groups. Surgeons will be un-
aware of block order.
Blinding
Surgeons, data collectors, and the data analyst will be
blind to group allocation. The addition of a LET proced-
ure results in a unique incision on the lateral side of the
knee between the lateral epicondyle and Gerdy’s tuber-
cle. The unblinded member of the research team will
place an opaque adhesive across the lateral side of the
knee covering the area where a LET incision could be
seen for clinical assessment and range of motion. Clin-
ical assessment will be completed by an independent as-
sessor (an experienced surgeon that did not perform the
surgical procedure on the patient). Participants will be
asked to wear a tubigrip sleeve over the operative knee
during all functional testing to conceal the incisions.
Table 2 Participant Timeline
Assessments Appointment
Baseline Surgery 3 Months 6 Months 12 Months 24 Months
Demographics X
Surgery Forms X
ACLQOL X X X X X
IKDC X X X X X
KOOS X X X X X
Euro-QOL X X X X X
MARS X X X X X
LEFS X X X X X
P4 X X X X X
Return to Sport X X X
ROM X X X X X
Clinical Assessment X X X X X
Radiographs X X X
Adverse Event Form X X X X X
Strength Testing X X X X
Hop Testing X X X
Drop Vertical Jump Testing X X
Root Tear MRI X X
Two Year MRI X
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Sample size
We estimate that within this group of high-risk patients
that the absolute risk (AR) of graft failure (as defined
above) in the ACLR group will range from 25 to 35%.
We would consider a relative reduction in re-rupture
rate of at least 40% to merit a change in practice (i.e. of
sufficient magnitude to warrant the additional costs
related to the procedure). Thus, with 255 patients per
group and a type 1 error rate of 5% we would have
approximately 80% power to detect a relative risk reduc-
tion (RRR) in rate of re-rupture in the LET of 40% or
greater. Because we expect a combined withdrawal and
lost-to-follow-up rate of about 15%, we will recruit a
total of 600 patients (300 per group).
Plan for statistical analysis
We will determine the absolute risk of graft failure in
each group, calculate a relative risk (RR) and risk differ-
ence (RD) of graft failure with 95% confidence intervals
around the estimate and use a Mantel Haentzel Test
(random effect of surgeon) to determine the significance
of the association between the addition of LET and graft
failure rates. We will calculate the number needed to
treat (NNT) to describe the number of patients who
need to receive LET to prevent one graft failure over the
first two postoperative years. We will calculate the mean
and standard error (ACL-QOL, KOOS, EuroQoL) for
each group at each time point and calculate the mean
between-group difference with 95% confidence interval
at 1 and 2 years postoperative. We will perform mixed
model analyses, where time is a categorical fixed effect;
treatment group, and sex are fixed effects, and patient
and surgeon are random effects, to determine whether
the difference between groups is of sufficient magnitude
to make a definitive conclusion about the effectiveness
of ACLR with LET compared to ACLR alone. Then, we
will plot each health status score by time and by group
to illustrate the change over time. We will conduct a
similar analysis for all continuous outcome variables.
Finally, for ease of interpretability, we will calculate the
number of patients in each group who achieve a change
at least as large as the MCID for an individual patient.
We will present the NNT to describe the number of
patients who need to undergo LET for one person to
achieve an important change in HRQOL.
For qMRI analysis, T1rho and T2 relaxation maps are
generated using software developed in-house by fitting
image intensities of the T1rho and T2 weighted images
pixel-by-pixel to the eq. S(TE) ∝ exp.(−TE/T2) using a
Levenberg-Marquardt mono-exponential fitting algo-
rithm. Load-bearing central, anterior, and posterior
regions of medial and lateral articular cartilage of the
femur and tibia are manually segmented and analyzed
using 3D Slicer software. The reader is blind to scan
order. We will use an independent t-test to evaluate
whether the T1rho and T2 relaxation times between
groups for all nine cartilage segments are statistically sig-
nificant. We will present means, standard deviations and
95% confidence intervals for interpretation.
Data collection methods
The timing of follow-up assessments corresponds with
regular visits to the surgeon following ACLR. During
these visits, the research assistant will administer the
questionnaires to ensure they are complete. Alterna-
tively, the patient can complete the questionnaires
online within the visit window by directly accessing the
electronic data capture (EDC) system (Empower Health
Research). A blinded surgeon will complete the knee
exam and a blinded kinesiologist will conduct the hop
and strength tests within the clinic at 6, 12, and 24
months postoperative. Participants will complete the
DVJ test at their 6- and 12-month visit in WOBL.
MRI’s will be conducted at Robarts Research Institute
located adjacent to the lead site and a radiologist,
blind to group allocation, will report MRI findings
using a standardized form.
Discussion
ACL injury is one of the most common orthopedic knee
injuries and, despite advances in surgical technique and
rehabilitation protocols, up to 30% of patients will
re-tear their graft or suffer a contra-lateral ACL injury
with younger age groups particularly at risk [16, 49].
Persistent instability leads to worse patient outcomes
following ACLR and biomechanical cadaveric studies
have shown that an ACLR alone may be insufficient to
restore normal rotation. A 2015 meta-analysis of 29
studies (8 randomized, 21 non-randomized) comparing
ACLR alone with ACLR and LET found the addition of
a LET reduces rotational laxity by a statistically signifi-
cant amount however, studies comparing the two proce-
dures demonstrated limitations including small sample
size and potential risk of bias [31].
The protocol for the Stability Study is the first ad-
equately powered RCT to study the effects of whether
augmenting ACLR with a LET reduces failure in young,
high-risk patients. Two further potential strengths of this
study are the addition of functional and biomechanical
testing and quantitative MRI to the protocol. Functional
and biomechanical testing are measures of neuromuscu-
lar training and patterning that require muscle strength,
proprioception and balance to complete [50], all of
which are important components in rehabilitation and
injury prevention [51, 52]. Despite high re-injury rates
and issues returning to pre-injury levels of sport follow-
ing ACLR, few high-quality studies include comparison
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of functional and biomechanical outcomes between
groups [53].
Concerns that the addition of an LET to the lateral side
of the joint may increase the risk of post-traumatic OA
will be addressed by the addition of qMRI to the trial. A
recent systematic review found that radiographic evidence
of OA was not significantly increased in patients where
ACLR was augmented with LET compared to ACL alone
[54]. Patients were assessed for radiographic evidence of
OA however follow-up length and results were variable
between studies. Using qMRI to evaluate cartilage degen-
eration allows us to compare articular cartilage health
between groups through T1Rho and T2 relaxation times;
increased relaxation times have been shown to be predict-
ive of the development of OA [46].
High graft failure rates following ACLR, particularly in
young, active patients, are concerning and need to be
addressed. It has been suggested that poor rotational
control following ACLR may predispose patients to graft
failure, which leads us to believe there may be a role for
augmenting the ACLR with an extra-articular recon-
struction. Previous studies combining ACLR and a LET
showed promising results, though small sample sizes
and potential biases limit the conclusions we can make.
The Stability study protocol is for a multicenter, inter-
national, adequately powered RCT comparing ACLR
alone to ACLR combined with an LET. This study can
provide level-one evidence regarding the effect augment-
ing an ACLR with a LET has on graft stability, patient
quality of life, functional performance, biomechanics,
and radiographic outcomes, and has the potential to
change clinical practice.
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